Keywords: emea, validates, insmed, iplex, ma, usa, says

EMEA validates Insmed's Iplex MA

Article | 10 July 2006

Print This

Insmed of the USA says that the European Medicines Agency (EMEA) has validated its application to market Iplex (mecasermin rinfabate [ ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in